Evosep
Manufacturing · Denmark · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Edisonsvej 1 Fl 3, Odense C, Region Sydd...Website
www.evosep.comRevenue
$7.1 MillionIndustry
About Evosep
Evosep Org Chart
Is Evosep your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Evosep has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Evosep recently announced quarterly report
Funding: Get notified immidiatlly once Evosep has new funding data
Evosep, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Evosep
Click to see if Evosep had a recent Job posting/layoffs
Check out if Evosep is spiking on competitors!
Product Launch: Get notified when Evosep launches new products
Recommended Actions
Find VP level buyers at Evosep
Find 3 more new buyers
Company Profile Activity
Activity Insights
Evosep is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Evosep is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Evosep.
Evosep Tech Stack
A closer look at the technologies used by Evosep
Most Recent Scoops
Evosep News & Media
Introducing Evosep Proteomics to Standardize and Scale Proteomics for Research and Drug Development
Evosep announces the launch a unified sample-to-separation platform built for reproducibility, scalability, and AI-ready proteomic insights.Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026
Evosep announces a major advancement in QA for pharmaceutical and regulated laboratories with the introduction of IQ/OQ protocols for its Evosep Eno systemWhite & Case advises Nordic Capital on acquisition of Evosep
Global law firm White & Case LLP has advised Nordic Capital on its acquisition of Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. As part of the transaction, minority shareholders EIFO and Novo Holdings will divest their respective shareholdings, while Evosep founders Ole Vorm and Matthias Mann will remain invested in the company.Nordic Capital to partner with Evosep, a leader in proteomics technologies for the global life science industry
ODENSE, Denmark, Nov. 18, 2025 /PRNewswire/ -- Nordic Capital today announced an agreement to become the majority owner in Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. The investment, leveraging Nordic Capital's experience...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Evosep
Evosep is dedicated to enhancing patient care and quality of life through innovative protein-based clinical diagnostics. They offer advanced solutions like the Evosep Eno and Evotip, which streamline sample preparation and separation processes, making them significantly faster and more robust. Their products cater to researchers in the fields of pr... Read More